GSK3 Inhibitors and Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|9|1024-1029

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.9, 2009-08, pp. : 1024-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

GSK-3 inhibitors and their potential in the treatment of Alzheimer’s disease

By Kypta Robert M  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1315-1331

Informa Healthcare

Access to resources Recommend Favorite

GSK-3 Inhibitors: Discoveries and Developments

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 755-763

Bentham Science Publishers

Access to resources Recommend Favorite

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3361-3369

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors

By  

Current Pharmaceutical Design, Vol. 16, Iss. 24, 2010-08 ,pp. : 2666-2675

Bentham Science Publishers

Access to resources Recommend Favorite